Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling is a research paper published in Leukemia Research (2022). On theSindex it has a DataRank of 0.613. It has been cited 9 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0.268
From 7 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
National Institutes of Health
Grant: UG1CA232760
National Institutes of Health
Grant: UG1CA233234
National Institutes of Health
Grant: UG1CA233290
National Institutes of Health
Grant: UG1CA189859
National Institutes of Health
Grant: U10CA180794
National Institutes of Health
Grant: U10CA180820
National Institutes of Health
Grant: P30 CA008748
American Society of Hematology
Grant: ASHAMFDP-20121
Robert Wood Johnson Foundation
Grant: U10 5U10CA180827
NCI NIH HHS
Grant: U10 CA180827
NCI NIH HHS
Grant: K08 CA169055
NCI NIH HHS
Grant: P50 CA254838
NCI NIH HHS
Grant: UG1 CA233332
NCI NIH HHS
Grant: U24 CA196172
National Cancer Institute
FWCI
0.89
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords